hov20210330_8k.htm
false 0000357294 0000357294 2021-03-30 2021-03-30 0000357294 hov:ClassACommonStockCustomMember 2021-03-30 2021-03-30 0000357294 hov:PreferredStockCustomMember 2021-03-30 2021-03-30 0000357294 hov:SeriesAPreferredStock7625CustomMember 2021-03-30 2021-03-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): March 30, 2021
 
HOVNANIAN ENTERPRISES, INC.
(Exact Name of Registrant as Specified in its Charter)
 
Delaware
(State or Other
Jurisdiction
of Incorporation)
1-8551
(Commission File Number)
22-1851059
(IRS Employer
Identification No.)
 
90 Matawan Road, Fifth Floor
Matawan, New Jersey 07747
(Address of Principal Executive Offices) (Zip Code)
 
(732) 747-7800
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former Name or Former Address, if Changed Since
Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act.
 
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Class A Common Stock $0.01 par value per share
HOV
New York Stock Exchange
Preferred Stock Purchase Rights (1)
N/A
New York Stock Exchange
Depositary Shares each representing 1/1,000th of a share of 7.625% Series A Preferred Stock
HOVNP
Nasdaq Global Market
 
(1) Each share of Class A Common Stock includes an associated Preferred Stock Purchase Right. Each Preferred Stock Purchase Right initially represents the right, if such Preferred Stock Purchase Right becomes exercisable, to purchase from the Company one ten-thousandth of a share of its Series B Junior Preferred Stock for each share of Common Stock. The Preferred Stock Purchase Rights currently cannot trade separately from the underlying Common Stock.
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company   
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
 
 

 
 
Item 5.02.      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
(e)     Amended and Restated 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan
 
On March 30, 2021, Hovnanian Enterprises, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders (the “2021 Annual Meeting”) at which the Company’s stockholders approved the Amended and Restated 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan (the “Amended Plan”), which had been previously recommended for approval by the Company’s Compensation Committee of the Board of Directors and previously approved by the Company’s Board of Directors, in each case, subject to stockholder approval. The Amended Plan became effective as of the date of such stockholder approval.
 
Prior to adoption of the Amended Plan, the Company had been granting equity-based incentive awards under the 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan (the “Existing Plan”). The Amended Plan is substantially identical to the Existing Plan, except it (i) increases the reserve of Class A common stock and Class B common stock for future grants by an aggregate of 300,000 shares and (ii) removes a provision that provided for the limited ability of the Company’s chief executive officer to accelerate the exercisability of stock options under certain circumstances.
 
The material features of the Amended Plan are described in the Company’s Definitive Proxy Statement filed on February 12, 2021 and Definitive Additional Materials filed on March 4, 2021 in connection with the 2021 Annual Meeting, which descriptions are filed herewith as Exhibit 99.1 and Exhibit 99.2, respectively, and incorporated herein by reference. The above and the incorporated descriptions of the Amended Plan are qualified in their entirety by reference to the Amended Plan, which is incorporated by reference herewith as Exhibit 10.1 and incorporated herein by reference.
 
Item 5.07.     Submission of Matters to a Vote of Security Holders.
 
The Company held its 2021 Annual Meeting on March 30, 2021. The matters voted upon at the 2021 Annual Meeting and the final results of the votes were as follows: 
 
(1)     Election of all directors of the Company to hold office until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified. Abstentions and broker non-votes had no effect on the outcome because such shares were not considered votes cast. The elected directors were:
 
   
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
                 
A. Hovnanian
 
7,496,582
 
41,696
 
31,510
 
1,687,617
R. Coutts
 
7,486,839
 
50,817
 
32,131
 
1,687,618
E. Kangas
 
7,434,946
 
102,818
 
32,024
 
1,687,617
J. Marengi
 
7,403,638
 
133,771
 
32,379
 
1,687,617
V. Pagano Jr.
 
7,366,077
 
164,013
 
39,698
 
1,687,617
R. Sellers
 
7,434,344
 
95,856
 
39,588
 
1,687,617
J. Sorsby
 
7,475,262
 
62,407
 
32,119
 
1,687,617
 
 
(2)     Ratification of the selection of Deloitte & Touche LLP as the Companys independent registered public accounting firm for the fiscal year ending October 31, 2021. Abstentions had no effect on the outcome because such shares were not considered votes cast.  There were no broker non-votes.
 
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
9,232,391
 
20,604
 
4,410
 
 
 

 
(3)      Approval of the Amended and Restated 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan. Under the rules of the New York Stock Exchange, abstentions were considered votes cast and, therefore, had the same effect as a vote against the proposal. Broker non-votes had no effect on the outcome because such shares were not considered votes cast.
 
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
7,389,692
 
168,486
 
11,610
 
1,687,617
 
 
(4)     Non-binding advisory vote on approval of the compensation of the Companys named executive officers as disclosed in the Proxy Statement. Abstentions and broker non-votes had no effect on the outcome because such shares were not considered votes cast.
 
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
6,498,680
 
1,055,985
 
15,122
 
1,687,618
 
 
(5)     Approval of an amendment to the Companys stockholder rights plan. Abstentions and broker non-votes had no effect on the outcome because such shares were not considered votes cast.
 
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
7,478,136
 
72,003
 
19,649
 
1,687,617
 
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits
   
     
Exhibit No.
 
Description
     
4.1
 
     
4.2
 
     
4.3
 
     
10.1
 
     
99.1
 
     
99.2
 
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
HOVNANIAN ENTERPRISES, INC.
(Registrant)
   
   
 
By: 
/s/ Elizabeth Tice                   
   
Name: Elizabeth Tice
Title: Vice President, Corporate Counsel and
Secretary
 
 
 
Date: March 30, 2021